相关实验视频
Updated: Jul 23, 2025

08:23
Comet Assay as an Indirect Measure of Systemic Oxidative Stress
Published on: May 22, 2015
29.4K
氧化应激和骨折的全球生物标志物:一个匹配的病例控制研究
Shuman Yang1,2, Lijie Feng1, Lisa M Lix3
1Department of Epidemiology and Biostatistics, School of Public Health, Jilin University, Changchun, Jilin, China.
Frontiers in endocrinology
|July 14, 2023
概括
高水平的特定光氧化产品 (FlOPs) 与老年人骨质疏松性骨折风险的增加有关. 这一发现突出了氧化应激作为骨健康和骨折的潜在因素.
科学领域:
- 氧化应激的生物标志物
- 骨健康和骨质疏松症研究
- 老年医学 老年医学
背景情况:
- 关于氧化应激和人类骨质疏松性骨折之间的联系的证据有限.
- 光氧化产物 (FlOP) 是全球生物标志物,反映了细胞组件的氧化损伤.
- 调查FLOPS作为骨质疏松性骨折风险的潜在指标至关重要.
研究的目的:
- 为了研究血光氧化产品 (FlOPs) 与中国老年人群中最近骨质疏松性骨折之间的关联.
- 确定特定的FlOP波长 (FlOP_320,FlOP_360,FlOP_400) 是否与骨折风险有关.
主要方法:
- 进行了一项病例控制研究,涉及44例骨折病例和88个匹配的对照 (50岁以上) 进行了.
- 使用光微板阅读器测量了血FLOP水平.
- 使用后勤回归分析来评估FLOPS与骨折风险之间的关联,并对共变量进行调整.
主要成果:
- FlOP_360 (OR=1.85) 和 FlOP_400 (OR=13.29) 的升高水平与骨质疏松性骨折风险的增加显著相关.
- FlOP_320没有显示出与骨折风险的显著关联 (OR=0.56).
- 对于FLOP_360和FLOP_400的关联在部和非部骨折中是一致的.
结论:
- 较高的Flop_360和Flop_400血水平与骨质疏松性骨折的风险增加有关.
- 观察到的FLOPS与骨折风险之间的关联在不同骨折部位上是可比的.
- 建议进行进一步的前性研究,以在不同人群中验证这些发现.
相关概念视频
Fractures: Bone Repair
3.4K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.4K
Bone Disorders
3.7K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K

